Industry Voice: China health care innovation

Why are we so excited by drug innovation in China?

clock • 1 min read

Initiatives to stimulate innovation, especially around drug research and development (R&D), have been the most impactful, in our view, says Invesco New York chief investment officer for developing markets equities and senior portfolio manager Justin Leverenz.

The result is a booming drug R&D ecosystem including quality biotechs and their R&D outsourcing partner companies.

We expect reforms to provide tremendous industry tailwinds for the next decade and, as long-term investors in this space, we are excited about the new opportunities that are being created.

 

 

 

Investment risks

The value of investments and any income will fluctuate (this may partly be the result of exchange rate fluctuations) and investors may not get back the full amount invested.

Important information

This article is for professional clients only and is not for consumer use.

Where individuals or the business have expressed opinions, they are based on current market conditions, they may differ from those of other investment professionals and are subject to change without notice.

Issued by Invesco Asset Management Limited, Perpetual Park, Perpetual Park Drive, Henley-on-Thames, Oxfordshire RG9 1HH, UK. Authorised and regulated by the Financial Conduct Authority.

Advertisement

More on Investment

XPS publishes annual fiduciary manager report

XPS publishes annual fiduciary manager report

Variation seen in performance during first and last quarters of 2024

Jasmine Urquhart
clock 22 April 2025 • 1 min read
PRA launches consultation to enable insurers to accelerate UK investment

PRA launches consultation to enable insurers to accelerate UK investment

Framework looks to reduce barriers to enable insurers to benefit from investment opportunities

Martin Richmond
clock 16 April 2025 • 2 min read
UK inflation falls to 2.6% in March amid warnings of further price rises

UK inflation falls to 2.6% in March amid warnings of further price rises

CPIH at 3.4% in March, with inflation down from previous month's 2.8%

Sorin Dojan
clock 16 April 2025 • 2 min read
Trustpilot